Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Jun;31(6):2784-2786.
doi: 10.1007/s11695-021-05259-3. Epub 2021 Feb 19.

Metabolic Outcomes of Percutaneous Transcathether Bariatric Embolotherapy: Insights from an RCT

Affiliations
Randomized Controlled Trial

Metabolic Outcomes of Percutaneous Transcathether Bariatric Embolotherapy: Insights from an RCT

Martin Fried et al. Obes Surg. 2021 Jun.
No abstract available

PubMed Disclaimer

References

    1. Reddy VY, Neužil P, Musikantow D, et al. Transcatheter bariatric embolotherapy for weight reduction in obesity. J Am Coll Cardiol. 2020;76(20):2305–17. - DOI
    1. Pareek M, Bhatt DL, Nielsen ML, et al. Enhanced predictive capability of a 1-hour oral glucose tolerance test: a prospective population-based cohort study. Diabetes Care. 2018;41(1):171–7. - DOI
    1. Alyass A, Almgren P, Akerlund M, et al. Modelling of OGTT curve identifies 1 h plasma glucose level as a strong predictor of incident type 2 diabetes: results from two prospective cohorts. Diabetologia. 2015;58(1):87–97. - DOI
    1. Jagannathan R, Sevick MA, Fink D, et al. The 1-hour post-load glucose level is more effective than HbA1c for screening dysglycemia. Acta Diabetol. 2016;53(4):543–50. - DOI
    1. Peddinti G, Bergman M, Tuomi T, et al. 1-hour post-OGTT glucose improves the early prediction of type 2 diabetes by clinical and metabolic markers. J Clin Endocrinol Metab. 2019;104(4):1131–40. - DOI

Publication types

LinkOut - more resources